Literature DB >> 3919499

The significance of the number of centroblasts in centroblastic/centrocytic lymphomas. A long term study in a large group of patients.

W M Molenaar, H Bartels, J Koudstaal.   

Abstract

A group of 385 centroblastic/centrocytic lymphomas with long follow-up periods was subdivided on the basis of the relative number of centroblasts in the initial biopsies. Only minor differences in overall survival were found although a different survival pattern was observed between the groups. The transition into a high-grade malignant secondary centroblastic lymphoma correlated, at a statistically significant level, with the relative number of centroblasts in the initial biopsy.

Entities:  

Mesh:

Year:  1985        PMID: 3919499     DOI: 10.1007/bf00710068

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  14 in total

1.  Malignant lymphomas of follicular center cell origin in man. III. Prognostic features.

Authors:  R S Stein; J Cousar; J M Flexner; S E Graber; L C McKee; S Krantz; R C Collins
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

Review 2.  Malignant lymphomas--a conceptual understanding of morphologic diversity. A review.

Authors:  R B Mann; E S Jaffe; C W Berard
Journal:  Am J Pathol       Date:  1979-01       Impact factor: 4.307

3.  Immunologic characterization of human malignant lymphomas.

Authors:  R J Lukes; R D Collins
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

4.  Non-Hodgkin's lymphomas: a clinicopathologic study of 293 cases.

Authors:  A S Patchefsky; H S Brodovsky; H Menduke; M Southard; J Brooks; D Nicklas; W S Hoch
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

5.  Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.

Authors:  S E Jones; Z Fuks; M Bull; M E Kadin; R F Dorfman; H S Kaplan; S A Rosenberg; H Kim
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

6.  The heterogeneity of follicular center cell lymphomas. I. Cytohistologic, immunologic, and enzymehistochemical aspects.

Authors:  W M Molenaar; M van den Berg; M R Halie; S Poppema
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

7.  Histologic progression in non-Hodgkin's lymphoma.

Authors:  S M Hubbard; B A Chabner; V T DeVita; R Simon; C W Berard; R B Jones; A J Garvin; G P Canellos; C K Osborne; R C Young
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

8.  The influence of histologic type on the incidence and duration of response in non-Hodgkin's lymphoma.

Authors:  R Herrmann; M Barcos; L Stutzman; D Walsh; A Freeman; J Sokal; E S Henderson
Journal:  Cancer       Date:  1982-01-15       Impact factor: 6.860

9.  Nodular malignant lymphomas: factors affecting complete response rate and survival.

Authors:  F Cabanillas; T Smith; G P Bodey; J U Gutterman; E J Freireich
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

10.  Histological, epidemiological and clinical aspects of centroblastic-centrocytic lymphomas subdivided according to the "working formulation".

Authors:  W M Molenaar; H Bartels; J Koudstaal
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.